SeqLL
Woburn, US · Founded 2014 · Delaware corporation
Founders & leadership
SeqLL was founded in 2014 by Daniel R. Jones and Georges St. Laurent III.
DR
Daniel R. JonesinCo-founder
GS
Georges St. Laurent IIICo-founder
TJ
Tisha JepsonExecutive
WS
William St. LaurentExecutive
ER
Elizabeth ReczekExecutive
Board
DM
Douglas MiscollBoard director
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 4 rounds · 2014–2020
▶$350KraisedFeb 2021 · 3 investors · Other TechnologyRule 506(b)
▶$350KraisedFeb 2021 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Dan JonesExecutive Officer
- John KennedyExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $350K
- Minimum investment
- $50K
- Sales commissions
- $20K
- Placement agents
- TerraNova Capital Equities, Inc.
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$120KraisedJun 2018 · 2 investors · BiotechnologyRule 506(b)
▶$120KraisedJun 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William St. LaurentDirector, Promoter
- Daniel R. JonesExecutive Officer, Director, Promoter
- Douglas MiscollDirector
- Charley CarterExecutive Officer
- Offering amount
- $1M
- Amount sold
- $120K
- Minimum investment
- $40K
- Sales commissions
- $160K
- Placement agents
- TerraNova Capital Equities, Inc., Network 1 Financial Securities Inc.
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1MraisedFeb 2016 · 2 investors · BiotechnologyRule 506(b)
▶$1MraisedFeb 2016 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tisha JepsonExecutive Officer
- William St. LaurentExecutive Officer, Director, Promoter
- Elizabeth ReczekExecutive Officer
- Daniel R. JonesExecutive Officer, Director, Promoter
- Douglas MiscollDirector
- Offering amount
- $1.5M
- Amount sold
- $1M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1MraisedJun 2014 · 9 investors · BiotechnologyRule 506(b)
▶$1MraisedJun 2014 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tisha JepsonExecutive Officer
- William St. LaurentExecutive Officer, Director, Promoter
- Daniel R. JonesExecutive Officer, Director, Promoter
- Georges St. Laurent IIIExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $1M
- Proceeds to insiders
- $25K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with SeqLL for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $223.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded SeqLL?
- SeqLL was founded by Daniel R. Jones, Georges St. Laurent III in 2014.
- How much funding has SeqLL raised?
- SeqLL has disclosed $2.5M raised across 4 rounds.
- Where is SeqLL headquartered?
- SeqLL is headquartered in Woburn, US.